Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc SPON ADR American Depositary Shares
(ADS)
|
Identification code
|
ISIN: US83175M2052
|
Nature of the transaction
|
Purchase of American Depository Shares as participants of the
Company's Employee Stock Purchase Plan
|
Date of Transaction
|
2024-07-5
|
Place of Transaction
|
New York Stock Exchange
|
Name
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
21.06
|
465.54938
|
N/A Single Transaction
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
21.06
|
465.54938
|
N/A Single Transaction
|
Craig Gaffin
(President, Global Orthopaedics)
|
PDMR
|
21.06
|
465.54938
|
N/A Single Transaction
|
Mizanu Kebede
(Chief Quality & Regulatory Affairs Officer)
|
PDMR
|
21.06
|
108.48433
|
N/A Single Transaction
|
Scott Schaffner
(President, Sports Medicine)
|
PDMR
|
21.06
|
261.92498
|
N/A Single Transaction
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
July 12, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|